Okta slides as price-target cuts revive doubts about growth reacceleration
Okta shares fell about 3% as investors reacted to fresh analyst price-target cuts that flagged limited near-term reacceleration. Morgan Stanley lowered its target to $101 from $110 while keeping an Overweight rating, reinforcing the “waiting for growth to reaccelerate” narrative.
1. What’s moving the stock
Okta (OKTA) traded lower in the session, extending recent post-earnings volatility as the market digested another round of analyst target reductions. The latest note highlighted that while results have been broadly in line with buy-side expectations, investors are still looking for clearer evidence of growth reacceleration to act as the next major catalyst. (tipranks.com)
2. The new catalyst: price-target cut, catalyst debate continues
Morgan Stanley cut its Okta price target to $101 from $110 while maintaining an Overweight rating. The note framed the setup as “ingredients” for reacceleration via product traction, but emphasized the market still lacks a firm commitment or clear timeline for that reacceleration—keeping pressure on the shares when risk appetite fades. (tipranks.com)
3. Context investors are weighing now
Okta’s shares have been sensitive to incremental shifts in expectations after its recent quarter, where performance beat forecasts but the stock reaction remained cautious. With the stock now trading well below many published targets, near-term direction is increasingly being driven by whether investors believe product-driven momentum will show up quickly enough to change the growth narrative. (investing.com)